Physician profile
Scott A Akers
NPI 1982965851
$917.10
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2021: $29.18 · 2022: $176 · 2023: $143 · 2024: $57.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $218.10 | 2019-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $169.59 | 2019-2023 | |
| Amgen INC. | $90.69 | 2019-2023 | Repatha, Otezla |
| Lilly USA, LLC | $83.45 | 2019-2022 | |
| Corium, LLC | $46.10 | 2022-2023 | Adlarity |
| Shire North American Group INC | $45.21 | 2019 | |
| Abbvie INC. | $34.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.79 | 2019-2024 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $25.86 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $24.50 | 2019-2024 | Xarelto |
| Nestle Healthcare Nutrition INC. | $23.59 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.99 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.27 | 2022 | |
| Merck Sharp & Dohme LLC | $15.34 | 2019 | |
| Astellas Pharma US INC | $13.82 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $13.60 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.41 | 2022 | |
| Exact Sciences Corporation | $13.21 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $12.56 | 2019 | |
| Sumitomo Pharma America, INC. | $10.31 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Akers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.